PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
ED  - Zarbin, Marco
TI  - Ranibizumab 0.5 mg Safe and Effective for Treatment of DME
DP  - 2014  01
TA  - MD Conference Express
PG  - 8--9
VI  - 14
IP  - 43
4099  - http://mdc.sagepub.com/content/14/43/8.short
4100  - http://mdc.sagepub.com/content/14/43/8.full
AB  - This article discusses a post hoc analysis of 5 studies of the humanized monoclonal antibody ranibizumab directed against vascular endothelial growth factor-A in the treatment of diabetic macular edema. The analysis focuses on the arterial thromboembolic events associated with ranibizumab that have been reported in controlled clinical trials.